Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Abicipar pegol (AGN-150998, MP0112), an anti-VEGF DARPin molecule, represents a novel class of small ankyrin repeat domain-containing proteins designed for high specificity and affinity targeting. This compound is adept at inhibiting angiogenesis and vascular permeability. It has seen applicative use in ocular inflammation-related disease studies through intravitreal injections, notably decreasing mean retinal thickness and leakage area [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Abicipar pegol (AGN-150998, MP0112), an anti-VEGF DARPin molecule, represents a novel class of small ankyrin repeat domain-containing proteins designed for high specificity and affinity targeting. This compound is adept at inhibiting angiogenesis and vascular permeability. It has seen applicative use in ocular inflammation-related disease studies through intravitreal injections, notably decreasing mean retinal thickness and leakage area [1] [2]. |
Molecular Weight | N/A |
CAS No. | 1327278-94-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Abicipar pegol 1327278-94-3 inhibitor inhibit